17/05/2024  20:53:38 Var. +0.50 Volume Denaro20:53:49 Lettera20:53:49 Capitalizzazione di mercato Dividend Y. Rapporto P/E
174.21USD +0.28% 1.17 mill.
Fatturato: 150.02 mill.
174.17Quantità in denaro: 200 174.24Quantità in lettera: 200 79.39 bill.USD 0.89% 34.25

Descrizione business

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Kristin Peck
Consiglio di amministrazione
Wetteny Joseph, Nick Ashton, Jamie Brannan, Heidi Chen, Rimma Driscoll, Jeannette Ferran Astorga, Roxanne Lagano, Wafaa Mamilli, Robert Polzer
Consiglio di sorveglianza
Michael McCallister, Paul M. Bisaro, Vanessa Broadhurst, Frank D’Amelio, Sanjay Khosla, Antoinette R. Leatherberry, Gregory Norden, Louise M. Parent, Kristin Peck, Dr. Willie M. Reed, Dr. Linda Rhodes, Robert Scully
 

Dati aziendali

Name: Zoetis Inc.
Indirizzo: 10 Sylvan Way,Parsippany, New Jersey 07054, USA
Telefono: +1-973-822-7000
Fax: -
E-mail: -
Internet: www.zoetis.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 83.54%
Data dell'IPO: 01/02/2013

Rapporti con gli investitori

Name: Steve Frank
IR telefono: +1-973-822-7141
IR Fax: -
IR e-mail: steve.frank@zoetis.com

Company calendar

CW 23 | 04/06/2024 Dividend Payment